[The specifities of the HPV-genital infections in males].
Anogenital infections caused by Human papillomavirus (HPV) are the most frequently diagnosed sexually transmitted infections of viral origin and up to 150 HPV DNA types have been recognized so far. Anogenital warts (condylomata acuminata) are the most common lesions presented in men, however, during the last decade the other HPV-associated exaggerated lesions such as condylomata plana, penile, scrotal, and anal intraepithelial neoplasias, as well as the penile, urine bladder and prostate cancer have been studied somewhat more extensively. The clinical variations might range from clinically invisible, asymptomatic lesions to the bizarre forms of giant condyloma of Buschke-Löwenstein type, including Bowenoid papulosis, Mb. Bowen, different kinds of eryhtroplasia both in men and women and a large spectrum of HPV-induced dermatovenereological entities in genital region including high-grade intraepithelial genital neoplasias, such as penile, anal, scrotal, vulvar, vaginal etc. (thus not only cervical), and, last but not least - the anogenital warts. A prophylactic vaccine that targets these types should thus substantially reduce the burden of HPV-associated clinical diseases. Ultimately, within the spectrum of therapeutic options for condylomata, no method is really superior to others; recurrences occurred in 30-70% of cases. We definitely need the HPV vaccination programme to eliminate one of the oldest and up to now unsolved problems of the mankind. Since HPV is transmitted by sexual intercourse, treatment of both partners is necessary in order to eliminate the virus from the population. Approaches to this include prophylactic vaccines such as quadrivalent HPV vaccine for both men and women.
University Department of Dermatology and Venereology, Zagreb University Hospital Centre and Zagreb University School of Medicine, Zagreb, Croatia. mskerlev@kbc-zagreb.hr
Mihael
M
Skerlev
Suzana
S
Ljubojevic
D005832:Genital Diseases, Male / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D053918:Papillomavirus Vaccines; D015229:Sexually Transmitted Diseases, Viral / Q000175:diagnosis / Q000628:therapy; D014565:Urogenital Neoplasms / Q000821:virology
D053918:Papillomavirus Vaccines